+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 60Years +
All Genders
ID06638710

Evaluating Oral Midazolam for Care Delivery in Older Adults with Moderate to Severe Neurocognitive Disorders Who Refuse Care

Led by University Hospital, Grenoble · Updated on 2025-12-15

30

Participants Needed

1

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of oral midazolam to help deliver care to elderly patients with moderate to severe neurocognitive disorders who resist care. These disorders can cause behavioral issues, making treatments challenging. Midazolam is known for reducing anxiety and agitation, with benefits like quick action and good tolerability. This study aims to assess the effectiveness and safety of an oral form of midazolam designed for elderly patients to improve care delivery. Participants will receive either an oral dose of midazolam or a placebo when they show resistance to care, as measured by a specific scale. The treatment is given by a nurse and is randomized and blinded, meaning neither the patient nor the care team knows which treatment is given. The study focuses on essential nursing and technical care activities that patients often refuse, such as bathing, wound care, and medication administration. During the study, researchers will monitor patients resistance and agitation levels before and after treatment, acceptance of care, adverse events, and the satisfaction of caregiving staff. These evaluations use established scales and occur at specific times around care delivery. The study includes safety monitoring over four months and aims to understand how oral midazolam affects care performance and patient behavior in this population.

CONDITIONS

Brief Title

Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care.

Research Team

V

Virginie GARNIER, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here